Author: Pettengell Ruth
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.69, Iss.13, 2009-09, pp. : 1727-1737
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rituximab worth it in advanced-stage NHL?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
By Prica Anca Chan Kelvin Cheung Matthew
Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. :
Should patients with severe sepsis receive drotrecogin alfa?
Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. :
Should Pediatric Patients with Hyperlipidemia Receive Drug Therapy?
By Bhatnagar D.
Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. :
Pharmacogenetics: useful tool for tailoring chemotherapy?
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :